Skip to main content
. 2022 Aug 16;5(3):372–387. doi: 10.3138/canlivj-2021-0038

Figure 2:

Figure 2:

Assessment of UDCA treatment response Proportion of patients categorized as responders and incomplete responders to UDCA therapy according to the Toronto criteria (ALP ≤200 IU/L, total bilirubin ≤21 µmol/L), and Paris-II criteria (ALP ≤180 IU/L, AST ≤60 IU/L, total bilirubin ≤21 µmol/L)

UDCA = Ursodeoxycholic acid; ALP = Alkaline phosphatase; AST = Aspartate aminotransferase